Australia’s largest healthcare company, Symbion Health Ltd. (Melbourne), is now under the control of the country’s second largest medical center operator, Primary Health Care Ltd. (Sydney), and the acquisition is set to have a major impact on the country’s estimated $A2.4 billion (U.S.$2.2 billion) pathology market by consolidating two of the four primary providers.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

March 2008 - Table of Contents

LIR March 2008 (full PDF issue)

More Labs Turn to Alternative Competitive Strategies as Contract Prices Decline

Quest Projects 9% Growth in 2008 Revenues, LabCorp Sees 13%

Physicians Name Insurance, Billing Woes as Top Nat’l Lab Complaints

Benchmarking the National Labs—Quest and LabCorp Post Gains in Revenue per FTE

As Managed Care Upheavals Subside, It’s Time for Labs to Strategize

San Diego Labs Hope for Injunction to Halt Comp Bidding Demo

Symbion Deal Consolidates Australia’s Pathology Market

As Quest Boosts Sales Efforts, Here’s How to Compete

Lab Index Down 7% Over 5 Wks; Quest Down 5%, LabCorp Up 8% in February

UnitedHealth in NY AG Cuomo’s Crosshairs for Reimbursement Fraud